激活转录因子3是一种新的生物标志物与清细胞癌进展的相关性
Zhicong Yang1, Yongwang Hou2, Jingqi Li1
1Central Laboratory, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.
International journal of immunopathology and pharmacology
|January 22, 2024
概括
活性转录因子3 (ATF3) 在清细胞细胞癌 (ccRCC) 中降低,表明它可能是预后预测因素. 在CCRCC中,PAXIP1-AS2和OIP5-AS1/hsa-miR-221-3p/ATF3轴可以调节apoptosis.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 清细胞细胞癌 (ccRCC) 是一种具有高转移和复发率的侵袭性癌症.
- 迫切需要ccRCC的新型预后预测因子和治疗点.
- 激活转录因子3 (ATF3) 是一种具有双重致癌/抑制作用的基因,在ccRCC中尚未得到充分研究.
研究的目的:
- 调查ccRCC中ATF3的预后价值.
- 在ccRCC中识别ATF3的潜在上游调节者,包括microRNAs (miRNAs) 和长非编码RNAs (lncRNAs).
- 探索ATF3在ccRCC中的功能性作用,特别是与内质网膜 (ER) 应激和亡有关.
主要方法:
- 利用基于TCGA的在线数据库来分析ccRCC中的ATF3表达和患者预后.
- 使用StarBase数据库来预测上游的miRNAs和lncRNAs针对ATF3.
- 进行了基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 分析,以推断ATF3功能.
- 进行了相关性分析,以评估ATF3表达和ER压力之间的关系.
主要成果:
- 与正常组织相比,ccRCC组织中ATF3表达显著下降.
- 较低的ATF3表达与ccRCC患者的预后较差密切相关.
- Hsa-miR-221-3p被确定为ATF3.3.的潜在miRNA调节器.
- 预测PAXIP1-AS2和OIP5-AS1是调节hsa-miR-221-3p/ATF3轴的关键上游 lncRNA.
- ATF3 参与调节 ER 应激反应中的亡信号,ATF3 表达和 ER 应激之间存在正相关性.
结论:
- 在ccRCC中,ATF3的调控下降,并作为负预后生物标志物.
- lncRNAs PAXIP1-AS2和OIP5-AS1,以及hsa-miR-221-3p/ATF3轴,是ccRCC中ER压力诱导的亡的潜在调节者.
- 这些发现突出了一个新的监管途径,对ccRCC有潜在的治疗影响.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


